Primary or secondary antifungal prophylaxis in patients with hematological maligancies: efficacy and damage

BACKGROUND: Patients with hematological malignancies often develop febrile neutropenia (FN) as a complication of cancer chemotherapy. Primary or secondary antifungal prophylaxis is recommended for patients with hematological malignancies to reduce the risk of invasive fungal infection (IFI). This st...

Descripción completa

Detalles Bibliográficos
Autores principales: Gedik, Habip, Şimşek, Funda, Yıldırmak, Taner, Kantürk, Arzu, Arıca, Deniz, Aydın, Demet, Demirel, Naciye, Yokuş, Osman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011927/
https://www.ncbi.nlm.nih.gov/pubmed/24855365
http://dx.doi.org/10.2147/TCRM.S59683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011927/
https://www.ncbi.nlm.nih.gov/pubmed/24855365
http://dx.doi.org/10.2147/TCRM.S59683

Ejemplares similares